Eikon Therapeutics

formerly EikonIPO

Bringing breakthrough therapeutics to patients with serious illnesses

Eikon Therapeutics is an artificial intelligence company in Hayward, United States, founded in 2019. It has raised $1.1B across 4 rounds, most recently a $350.7M Series D in February 2025.

Employees
201–500
Founded
2019
Business Model
B2B
Total Funding
$1.1B
Last Round
$350.7M Series DFeb 2025
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 9 investors for this company. to use credits for reveals, or explore the API.

About

Eikon Therapeutics is a clinical-stage biopharmaceutical company that has built the world's first high-throughput single-molecule tracking (htSMT) platform, enabling visualization of hundreds of thousands of protein motion events in living cells in under a second. Founded on Nobel Prize-winning super-resolution microscopy by Eric Betzig, Eikon uses this platform to discover and develop breakthrough oncology and neurological therapeutics. The company completed an IPO in early 2026, raising $381 million.

Funding & Exit History

Data from Indexed.vcUpdated
IPOFeb 2026
$381.0M

4 more events

  • Series D20258 investors
  • Series C2023
  • Series B20222 investors

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Cloud/Infrastructure ×1
  • Database ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech
Extension RoundTotal funding$1.2BNov 2021
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech
Series BTotal funding$612.0MOct 2022
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Eikon Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/eikon-therapeutics"><img src="https://indexed.vc/api/badge/company/eikon-therapeutics" alt="Eikon Therapeutics on Indexed.vc" width="260" height="76" /></a>